V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003753 | 210013375 | 1.74 | 61.2 | Palliative (P) | 2020-07-29 | 2021-12-04 | Olaparib | 02 | N | FEC + DOCETAXEL | 100556658 |
| 210003754 | 210013376 | 1.44 | 128 | Adjuvant (A) | 2019-09-20 | 2020-05-08 | TCH (21 day Trastuzumab) Maint | 02 | N | LETROZOLE + PALBOCICLIB | 100575774 |
| 210003768 | 210013379 | 1.65 | 59.8 | Palliative (P) | 2021-01-13 | 2021-04-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101547987 |
| 210003779 | 210013383 | 1.71 | 68.2 | Adjuvant (A) | 2019-06-25 | 2019-10-24 | Capecitabine | 01 | N | CAPECITABINE | 101717009 |
| 210003783 | 210013385 | 1.68 | 101.6 | null | null | 2021-08-12 | Neratinib | 02 | null | NERATINIB | 100235204 |
| 210003792 | 210013387 | 1.69 | 83.8 | Palliative (P) | 2020-12-05 | 2021-04-21 | Eribulin | 02 | N | ERIBULIN | 100133076 |
| 210003803 | 210013390 | 1.5 | 60.5 | null | 2020-12-07 | 2021-06-02 | null | 02 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100784792 |
| 210003808 | 210013393 | 1.81 | 79.4 | Palliative (P) | null | 2020-04-14 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100749803 |
| 210003809 | 210013394 | 1.7 | 84.4 | null | 2019-01-05 | 2021-01-08 | TRASTUZUMAB EMTANSINE | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101688181 |
| 210003811 | 210013395 | 1.72 | 100.3 | null | null | 2022-04-01 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 100844377 |
| 210003813 | 210013396 | 1.65 | 66.3 | Adjuvant (A) | null | 2021-10-11 | FEC + DOCETAXEL | null | N | FEC + DOCETAXEL | 101270324 |
| 210003819 | 210013399 | 1.67 | 83.9 | Neo-adjuvant (N) | null | 2019-10-15 | Eribulin | 02 | N | ERIBULIN | 100807799 |
| 210003821 | 210013400 | 1.47 | 65.9 | null | 2021-05-09 | 2021-07-27 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101309940 |
| 210003824 | 210013401 | null | null | Adjuvant (A) | 2019-01-09 | 2019-01-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100036411 |
| 210003826 | 210013402 | null | 94 | null | null | 2020-09-15 | ATEZOLIZUMAB + NAB PACLITAXEL | N | null | CYCLO + DOCETAXEL + TRASTUZUMAB | 101339951 |
| 210003829 | 210013403 | 1.7 | 64.4 | Adjuvant (A) | 2020-08-06 | 2020-08-19 | Eribulin | 02 | N | ERIBULIN | 100506263 |
| 210003832 | 210013405 | 1.75 | 57 | null | null | 2019-10-20 | null | null | null | LETROZOLE + PALBOCICLIB | 100586130 |
| 210003844 | 210013407 | 1.72 | 103.9 | null | 2021-10-19 | 2021-10-19 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100348651 |
| 210003845 | 210013408 | 1.57 | 69.2 | null | 2022-01-15 | 2022-02-19 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100474186 |
| 210003846 | 210013409 | null | 77 | Neo-adjuvant (N) | null | 2017-04-27 | Vinorelbine IV | 02 | N | VINORELBINE | 101408426 |
| 210003850 | 210013411 | 1.59 | 67.1 | Neo-adjuvant (N) | 2020-01-04 | 2020-01-07 | Eribulin | 02 | null | ERIBULIN | 100865385 |
| 210003858 | 210013413 | 1.67 | 110.3 | Palliative (P) | 2017-01-31 | 2017-01-31 | Capecitabine | 02 | N | CAPECITABINE | 101594501 |
| 210003859 | 210013414 | 1.42 | 55 | null | 2020-02-15 | 2020-04-20 | Pertuzumab (Maintenance) | 02 | null | PERTUZUMAB | 100934002 |
| 210003862 | 210013415 | 1.59 | 79.2 | Adjuvant (A) | 2020-03-03 | 2020-03-04 | Trial Unspecified | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100376955 |
| 210003872 | 210013419 | 1.55 | 55.75 | null | 2021-12-01 | 2021-12-21 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 100048535 |
| 210003874 | 210013420 | 0 | 93.65 | Palliative (P) | null | 2019-08-15 | Fulvestrant + Palbociclib | N | N | EC | 101181685 |
| 210003876 | 210013421 | 1.5 | null | null | 2021-06-15 | 2021-06-22 | Eribulin | N | null | ERIBULIN | 100468627 |
| 210000730 | 210013428 | 1.71 | 65.3 | null | 2019-11-11 | 2019-12-24 | TCH (21 day Trastuzumab) Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 100737972 |
| 210000828 | 210013429 | 1.57 | 67.7 | null | 2021-12-01 | 2021-12-14 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 101773283 |
| 210001109 | 210013432 | 1.61 | 61.4 | Neo-adjuvant (N) | 2018-02-14 | 2018-06-30 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 100904517 |
| 210001126 | 210013434 | 1.52 | 100.8 | null | 2020-01-22 | 2020-03-18 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101674658 |
| 210001184 | 210013435 | 1.66 | 55.3 | Adjuvant (A) | 2017-10-13 | 2017-10-20 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100896768 |
| 210001443 | 210013437 | 1.66 | 57 | Adjuvant (A) | null | 2020-04-05 | Capecitabine | 02 | null | CAPECITABINE | 100966119 |
| 210001876 | 210013440 | 1.56 | 77.7 | Palliative (P) | 2020-05-07 | 2020-06-05 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100936518 |
| 210001961 | 210013441 | 1.69 | 108 | Neo-adjuvant (N) | 2020-12-15 | 2020-12-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101469850 |
| 210001994 | 210013442 | 1.59 | 110 | Palliative (P) | 2017-03-29 | 2020-01-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100155303 |
| 210002038 | 210013444 | 1.66 | 63.5 | Neo-adjuvant (N) | 2021-03-06 | 2021-05-22 | EC | null | N | EC | 101316970 |
| 210002052 | 210013445 | 1.62 | 68.2 | Neo-adjuvant (N) | null | 2021-11-02 | Capecitabine | 02 | N | CAPECITABINE | 100843902 |
| 210002107 | 210013447 | 1.81 | 72.7 | null | 2019-03-13 | 2019-11-13 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101536240 |
| 210002127 | 210013448 | 1.57 | 71.3 | null | 2021-05-07 | 2021-05-28 | EC | 02 | null | EC | 100657281 |
| 210002144 | 210013449 | 1.62 | 0 | null | null | 2021-08-04 | Capecitabine | N | null | CAPECITABINE | 100163344 |
| 210002362 | 210013451 | 1.66 | null | null | null | 2019-07-24 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100908757 |
| 210002412 | 210013452 | 1.52 | 78.7 | Adjuvant (A) | 2021-12-10 | 2021-12-10 | Capecitabine | 02 | N | CAPECITABINE | 100071313 |
| 210002443 | 210013454 | null | null | null | null | 2019-09-05 | null | 02 | null | CAPECITABINE + PERTUZUMAB + TRASTUZUMAB | 101261577 |
| 210002637 | 210013455 | 1.61 | 93.3 | Palliative (P) | 2022-03-27 | 2022-03-27 | TRASTUZUMAB EMTANSINE | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101493616 |
| 210002751 | 210013456 | 1.59 | 75 | null | 2019-06-05 | 2019-06-06 | null | 02 | null | TRIAL UNSPECIFIED | 100755182 |
| 210002942 | 210013457 | 1.72 | 56.7 | null | 2020-12-23 | 2021-03-13 | Neratinib | null | null | NERATINIB | 101053988 |
| 210003226 | 210013458 | 1.58 | 95.1 | Palliative (P) | 2020-07-12 | 2020-10-12 | Neratinib | 02 | N | NERATINIB | 100456723 |
| 210003252 | 210013459 | null | 94.8 | Palliative (P) | 2020-10-25 | 2022-01-28 | null | null | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101129757 |
| 210003324 | 210013460 | 1.6 | 71.5 | Adjuvant (A) | null | 2022-02-17 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100837867 |